Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects.
Hae Won LeeWoo Youl KangWookjae JungMi-Ri GwonDong Heon YangEun Hee KimKyunghee ChoYoung-Ran YoonSook Jin SeongPublished in: Translational and clinical pharmacology (2020)
ClinicalTrials.gov Identifier: NCT02988362.
Keyphrases